Cargando…

Comparison of the in-vitro efficacy of different mouthwash solutions targeting SARS-CoV-2 based on the European Standard EN 14476

The outbreak of the SARS-CoV-2 pandemic is triggering a global health emergency alert. Until vaccination becomes available, a bundle of effective preventive measures is desperately needed. Recent research is indicating the relevance of aerosols in the spread of SARS-CoV-2. Thus, in this study commer...

Descripción completa

Detalles Bibliográficos
Autores principales: Steinhauer, K., Meister, T.L., Todt, D., Krawczyk, A., Paßvogel, L., Becker, B., Paulmann, D., Bischoff, B., Pfaender, S., Brill, F.H.H., Steinmann, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of The Healthcare Infection Society. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876484/
https://www.ncbi.nlm.nih.gov/pubmed/33582201
http://dx.doi.org/10.1016/j.jhin.2021.01.031
_version_ 1783649983527911424
author Steinhauer, K.
Meister, T.L.
Todt, D.
Krawczyk, A.
Paßvogel, L.
Becker, B.
Paulmann, D.
Bischoff, B.
Pfaender, S.
Brill, F.H.H.
Steinmann, E.
author_facet Steinhauer, K.
Meister, T.L.
Todt, D.
Krawczyk, A.
Paßvogel, L.
Becker, B.
Paulmann, D.
Bischoff, B.
Pfaender, S.
Brill, F.H.H.
Steinmann, E.
author_sort Steinhauer, K.
collection PubMed
description The outbreak of the SARS-CoV-2 pandemic is triggering a global health emergency alert. Until vaccination becomes available, a bundle of effective preventive measures is desperately needed. Recent research is indicating the relevance of aerosols in the spread of SARS-CoV-2. Thus, in this study commercially available antiseptic mouthwashes based on the active ingredients chlorhexidine digluconate and octenidine dihydrochloride (OCT) were investigated regarding their efficacy against SARS-CoV-2 using the European Standard 14476. Based on the requirement of EN 14476 in which reduction of at least four decimal logarithms (≥4 log(10)) of viral titre is requested to state efficacy, the OCT-based formulation was found to be effective within a contact time of only 15 s against SARS-CoV-2. Based on this in-vitro data the OCT mouthwash thus constitutes an interesting candidate for future clinical studies to prove its effectiveness in a potential prevention of SARS-CoV-2 transmission by aerosols.
format Online
Article
Text
id pubmed-7876484
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Authors. Published by Elsevier Ltd on behalf of The Healthcare Infection Society.
record_format MEDLINE/PubMed
spelling pubmed-78764842021-02-11 Comparison of the in-vitro efficacy of different mouthwash solutions targeting SARS-CoV-2 based on the European Standard EN 14476 Steinhauer, K. Meister, T.L. Todt, D. Krawczyk, A. Paßvogel, L. Becker, B. Paulmann, D. Bischoff, B. Pfaender, S. Brill, F.H.H. Steinmann, E. J Hosp Infect Short Report The outbreak of the SARS-CoV-2 pandemic is triggering a global health emergency alert. Until vaccination becomes available, a bundle of effective preventive measures is desperately needed. Recent research is indicating the relevance of aerosols in the spread of SARS-CoV-2. Thus, in this study commercially available antiseptic mouthwashes based on the active ingredients chlorhexidine digluconate and octenidine dihydrochloride (OCT) were investigated regarding their efficacy against SARS-CoV-2 using the European Standard 14476. Based on the requirement of EN 14476 in which reduction of at least four decimal logarithms (≥4 log(10)) of viral titre is requested to state efficacy, the OCT-based formulation was found to be effective within a contact time of only 15 s against SARS-CoV-2. Based on this in-vitro data the OCT mouthwash thus constitutes an interesting candidate for future clinical studies to prove its effectiveness in a potential prevention of SARS-CoV-2 transmission by aerosols. The Authors. Published by Elsevier Ltd on behalf of The Healthcare Infection Society. 2021-05 2021-02-11 /pmc/articles/PMC7876484/ /pubmed/33582201 http://dx.doi.org/10.1016/j.jhin.2021.01.031 Text en © 2021 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Short Report
Steinhauer, K.
Meister, T.L.
Todt, D.
Krawczyk, A.
Paßvogel, L.
Becker, B.
Paulmann, D.
Bischoff, B.
Pfaender, S.
Brill, F.H.H.
Steinmann, E.
Comparison of the in-vitro efficacy of different mouthwash solutions targeting SARS-CoV-2 based on the European Standard EN 14476
title Comparison of the in-vitro efficacy of different mouthwash solutions targeting SARS-CoV-2 based on the European Standard EN 14476
title_full Comparison of the in-vitro efficacy of different mouthwash solutions targeting SARS-CoV-2 based on the European Standard EN 14476
title_fullStr Comparison of the in-vitro efficacy of different mouthwash solutions targeting SARS-CoV-2 based on the European Standard EN 14476
title_full_unstemmed Comparison of the in-vitro efficacy of different mouthwash solutions targeting SARS-CoV-2 based on the European Standard EN 14476
title_short Comparison of the in-vitro efficacy of different mouthwash solutions targeting SARS-CoV-2 based on the European Standard EN 14476
title_sort comparison of the in-vitro efficacy of different mouthwash solutions targeting sars-cov-2 based on the european standard en 14476
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876484/
https://www.ncbi.nlm.nih.gov/pubmed/33582201
http://dx.doi.org/10.1016/j.jhin.2021.01.031
work_keys_str_mv AT steinhauerk comparisonoftheinvitroefficacyofdifferentmouthwashsolutionstargetingsarscov2basedontheeuropeanstandarden14476
AT meistertl comparisonoftheinvitroefficacyofdifferentmouthwashsolutionstargetingsarscov2basedontheeuropeanstandarden14476
AT todtd comparisonoftheinvitroefficacyofdifferentmouthwashsolutionstargetingsarscov2basedontheeuropeanstandarden14476
AT krawczyka comparisonoftheinvitroefficacyofdifferentmouthwashsolutionstargetingsarscov2basedontheeuropeanstandarden14476
AT paßvogell comparisonoftheinvitroefficacyofdifferentmouthwashsolutionstargetingsarscov2basedontheeuropeanstandarden14476
AT beckerb comparisonoftheinvitroefficacyofdifferentmouthwashsolutionstargetingsarscov2basedontheeuropeanstandarden14476
AT paulmannd comparisonoftheinvitroefficacyofdifferentmouthwashsolutionstargetingsarscov2basedontheeuropeanstandarden14476
AT bischoffb comparisonoftheinvitroefficacyofdifferentmouthwashsolutionstargetingsarscov2basedontheeuropeanstandarden14476
AT pfaenders comparisonoftheinvitroefficacyofdifferentmouthwashsolutionstargetingsarscov2basedontheeuropeanstandarden14476
AT brillfhh comparisonoftheinvitroefficacyofdifferentmouthwashsolutionstargetingsarscov2basedontheeuropeanstandarden14476
AT steinmanne comparisonoftheinvitroefficacyofdifferentmouthwashsolutionstargetingsarscov2basedontheeuropeanstandarden14476